[Hypotensive effect of captopril in hypertensive patients with collagen disease]. 1983

K Fujino, and N Kurata, and M Kinashi, and J Takahara, and Z Ota, and T Ofuji

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010488 Polyarteritis Nodosa A form of necrotizing non-granulomatous inflammation occurring primarily in medium-sized ARTERIES, often with microaneurysms. It is characterized by muscle, joint, and abdominal pain resulting from arterial infarction and scarring in affected organs. Polyarteritis nodosa with lung involvement is called CHURG-STRAUSS SYNDROME. Essential Polyarteritis,Necrotizing Arteritis,Periarteritis Nodosa,Arteritides, Necrotizing,Arteritis, Necrotizing,Essential Polyarteritides,Necrotizing Arteritides,Polyarteritides, Essential,Polyarteritis, Essential
D011392 Proline A non-essential amino acid that is synthesized from GLUTAMIC ACID. It is an essential component of COLLAGEN and is important for proper functioning of joints and tendons. L-Proline,L Proline
D012084 Renin-Angiotensin System A BLOOD PRESSURE regulating system of interacting components that include RENIN; ANGIOTENSINOGEN; ANGIOTENSIN CONVERTING ENZYME; ANGIOTENSIN I; ANGIOTENSIN II; and angiotensinase. Renin, an enzyme produced in the kidney, acts on angiotensinogen, an alpha-2 globulin produced by the liver, forming ANGIOTENSIN I. Angiotensin-converting enzyme, contained in the lung, acts on angiotensin I in the plasma converting it to ANGIOTENSIN II, an extremely powerful vasoconstrictor. Angiotensin II causes contraction of the arteriolar and renal VASCULAR SMOOTH MUSCLE, leading to retention of salt and water in the KIDNEY and increased arterial blood pressure. In addition, angiotensin II stimulates the release of ALDOSTERONE from the ADRENAL CORTEX, which in turn also increases salt and water retention in the kidney. Angiotensin-converting enzyme also breaks down BRADYKININ, a powerful vasodilator and component of the KALLIKREIN-KININ SYSTEM. Renin-Angiotensin-Aldosterone System,Renin Angiotensin Aldosterone System,Renin Angiotensin System,System, Renin-Angiotensin,System, Renin-Angiotensin-Aldosterone
D002216 Captopril A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin. (S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline,Capoten,Lopirin,SQ-14,225,SQ-14,534,SQ-14225,SQ-14534,SQ 14,225,SQ 14,534,SQ 14225,SQ 14534,SQ14,225,SQ14,534,SQ14225,SQ14534
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

K Fujino, and N Kurata, and M Kinashi, and J Takahara, and Z Ota, and T Ofuji
November 1983, Methods and findings in experimental and clinical pharmacology,
K Fujino, and N Kurata, and M Kinashi, and J Takahara, and Z Ota, and T Ofuji
May 1980, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
K Fujino, and N Kurata, and M Kinashi, and J Takahara, and Z Ota, and T Ofuji
March 1971, Vrachebnoe delo,
K Fujino, and N Kurata, and M Kinashi, and J Takahara, and Z Ota, and T Ofuji
May 1983, British medical journal (Clinical research ed.),
K Fujino, and N Kurata, and M Kinashi, and J Takahara, and Z Ota, and T Ofuji
April 1983, British medical journal (Clinical research ed.),
K Fujino, and N Kurata, and M Kinashi, and J Takahara, and Z Ota, and T Ofuji
July 2006, Experimental physiology,
K Fujino, and N Kurata, and M Kinashi, and J Takahara, and Z Ota, and T Ofuji
December 1980, Clinical science (London, England : 1979),
K Fujino, and N Kurata, and M Kinashi, and J Takahara, and Z Ota, and T Ofuji
April 1989, The American journal of medicine,
K Fujino, and N Kurata, and M Kinashi, and J Takahara, and Z Ota, and T Ofuji
January 1975, Terapevticheskii arkhiv,
K Fujino, and N Kurata, and M Kinashi, and J Takahara, and Z Ota, and T Ofuji
November 1991, Zhong xi yi jie he za zhi = Chinese journal of modern developments in traditional medicine,
Copied contents to your clipboard!